The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Open accessAbstract
International audience
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Michie, S., van Stralen, M. M., & West, R. (2011) · Implementation Science · doi:10.1186/1748-5908-6-42 · Cited by 13,697
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Self-citationRivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Self-citationHeart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Self-citation2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
Self-citation2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
Self-citation2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Self-citation
Research works printed but not linked: 1261
- Calkins, 2018, 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary, Europace, 20, 157, 10.1093/europace/eux275 · DOI · Paper page
- Freedman, 2017, Management of atrial high-rate episodes detected by cardiac implanted electronic devices, Nat Rev Cardiol, 14, 701, 10.1038/nrcardio.2017.94 · DOI
- Perino, 2019, Practice variation in anticoagulation prescription and outcomes after device-detected atrial fibrillation, Circulation, 139, 2502, 10.1161/CIRCULATIONAHA.118.038988 · DOI
- Steinberg, 2018, Thirty-second gold standard definition of atrial fibrillation and its relationship with subsequent arrhythmia patterns: analysis of a large prospective device database, Circ Arrhythm Electrophysiol, 11, e006274, 10.1161/CIRCEP.118.006274 · DOI
- Camm, 2017, Atrial high-rate episodes and stroke prevention, Europace, 19, 169, 10.1093/europace/euw279 · DOI
- Pollak, 2001, Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter, Pacing Clin Electrophysiol, 24, 424, 10.1046/j.1460-9592.2001.00424.x · DOI
- Kaufman, 2012, Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT, Heart Rhythm, 9, 1241, 10.1016/j.hrthm.2012.03.017 · DOI · Paper page
- Colilla, 2013, Estimates of current and future incidence and prevalence of atrial fibrillation in the US adult population, Am J Cardiol, 112, 1142, 10.1016/j.amjcard.2013.05.063 · DOI · Paper page
- Krijthe, 2013, Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060, Eur Heart J, 34, 2746, 10.1093/eurheartj/eht280 · DOI · Paper page
- Dewland, 2013, Incident atrial fibrillation among Asians, Hispanics, blacks, and whites, Circulation, 128, 2470, 10.1161/CIRCULATIONAHA.113.002449 · DOI · Paper page
- Staerk, 2017, Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes, Circ Res, 120, 1501, 10.1161/CIRCRESAHA.117.309732 · DOI · Paper page
- Alonso, 2009, Incidence of atrial fibrillation in whites and African Americans: the Atherosclerosis Risk in Communities (ARIC) study, Am Heart J, 158, 111, 10.1016/j.ahj.2009.05.010 · DOI · Paper page
- Chao, 2018, Lifetime risks, projected numbers, and adverse outcomes in Asian patients with atrial fibrillation: a report from the Taiwan Nationwide AF Cohort Study, Chest, 153, 453, 10.1016/j.chest.2017.10.001 · DOI · Paper page
- Di Carlo, 2019, Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project, Europace, 21, 1468, 10.1093/europace/euz141 · DOI
- Mou, 2018, Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC study (Atherosclerosis Risk in Communities, Circ Arrhythm Electrophysiol, 11, e006350, 10.1161/CIRCEP.118.006350 · DOI · Paper page
- Boriani, 2015, Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making – a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society, Europace, 17, 1169, 10.1093/europace/euv202 · DOI · Paper page
- Aune, 2018, Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies, J Diabetes Complications, 32, 501, 10.1016/j.jdiacomp.2018.02.004 · DOI · Paper page
- Hobbelt, 2017, Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study, Europace, 19, 226
- Nalliah, 2018, The impact of diet and lifestyle on atrial fibrillation, Curr Cardiol Rep, 20, 137, 10.1007/s11886-018-1082-8 · DOI
- Lip, 2017, Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE), Europace, 19, 891, 10.1093/europace/eux091 · DOI · Paper page
- Gallagher, 2017, Alcohol and incident atrial fibrillation – a systematic review and meta-analysis, Int J Cardiol, 246, 46, 10.1016/j.ijcard.2017.05.133 · DOI · Paper page
- Ricci, 2018, Physical activity volume in relation to risk of atrial fibrillation. A non-linear meta-regression analysis, Eur J Prev Cardiol, 25, 857, 10.1177/2047487318768026 · DOI
- Magnussen, 2017, Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the BiomarCaRE Consortium (, Biomarker for Cardiovascular Risk Assessment in Europe). Circulation, 136, 1588
- Staerk, 2018, Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study, BMJ, 361, k1453, 10.1136/bmj.k1453 · DOI · Paper page
- Allan, 2017, Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants, Thromb Haemost, 117, 837, 10.1160/TH16-11-0825 · DOI · Paper page
- Feghaly, 2018, Genetics of atrial fibrillation, J Am Heart Assoc, 7, e009884, 10.1161/JAHA.118.009884 · DOI
- Alonso, 2014, Association of sick sinus syndrome with incident cardiovascular disease and mortality: the Atherosclerosis Risk in Communities Study and Cardiovascular Health Study, PLoS One, 9, e109662, 10.1371/journal.pone.0109662 · DOI
- Alonso, 2011, Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study, Circulation, 123, 2946, 10.1161/CIRCULATIONAHA.111.020982 · DOI · Paper page
- Andersen, 2013, Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study, Eur Heart J, 34, 3624, 10.1093/eurheartj/eht188 · DOI · Paper page
- Asad, 2018, Obesity is associated with incident atrial fibrillation independent of gender: a meta-analysis, J Cardiovasc Electrophysiol, 29, 725, 10.1111/jce.13458 · DOI
- Aune, 2017, Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies, Eur J Epidemiol, 32, 181, 10.1007/s10654-017-0232-4 · DOI · Paper page
- Bansal, 2017, eGFR and albuminuria in relation to risk of incident atrial fibrillation: a meta-analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study, Clin J Am Soc Nephrol, 12, 1386, 10.2215/CJN.01860217 · DOI
- Baumgartner, 2017, Thyroid Studies Collaboration. Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation, Circulation, 136, 2100, 10.1161/CIRCULATIONAHA.117.028753 · DOI · Paper page
- Bunch, 2015, Long-term natural history of adult Wolff-Parkinson-White syndrome patients treated with and without catheter ablation, Circ Arrhythm Electrophysiol, 8, 1465, 10.1161/CIRCEP.115.003013 · DOI
- Chang, 2017, Association of a family history of atrial fibrillation with incidence and outcomes of atrial fibrillation: a population-based family cohort study, JAMA Cardiol, 2, 863, 10.1001/jamacardio.2017.1855 · DOI
- Chen, 2016, Carotid intima-media thickness and arterial stiffness and the risk of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study, Multi-Ethnic Study of Atherosclerosis (MESA), and the Rotterdam Study, J Am Heart Assoc, 5, 10.1161/JAHA.115.002907 · DOI
- Cheng, 2009, Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block, JAMA, 301, 2571, 10.1001/jama.2009.888 · DOI · Paper page
- Conen, 2010, Caffeine consumption and incident atrial fibrillation in women, Am J Clin Nutr, 92, 509, 10.3945/ajcn.2010.29627 · DOI
- Desai, 2019, The burden and impact of arrhythmia in chronic obstructive pulmonary disease: insights from the National Inpatient Sample, Int J Cardiol, 281, 49, 10.1016/j.ijcard.2019.01.074 · DOI
- Giacomantonio, 2013, A systematic review of the health benefits of exercise rehabilitation in persons living with atrial fibrillation, Can J Cardiol, 29, 483
- Kirchhof, 2012, Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options – a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference, Europace, 14, 8, 10.1093/europace/eur241 · DOI · Paper page
- Ko, 2019, Proteomics profiling and risk of new-onset atrial fibrillation: Framingham Heart Study, J Am Heart Assoc, 8, e010976, 10.1161/JAHA.118.010976 · DOI
- Kwok, 2014, Physical activity and incidence of atrial fibrillation: a systematic review and meta-analysis, Int J Cardiol, 177, 467, 10.1016/j.ijcard.2014.09.104 · DOI
- Lip, 2017, Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: executive summary of a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE), Thromb Haemost, 117, 2215, 10.1160/TH-17-10-0709 · DOI
- Loomba, 2017, Arrhythmias in adults with congenital heart disease: what are risk factors for specific arrhythmias?, Pacing Clin Electrophysiol, 40, 353, 10.1111/pace.12983 · DOI
- Lubitz, 2010, Association between familial atrial fibrillation and risk of new-onset atrial fibrillation, JAMA, 304, 2263, 10.1001/jama.2010.1690 · DOI · Paper page
- May, 2016, Outcomes of Sleep Disorders in Older Men) Study Group. Central sleep-disordered breathing predicts incident atrial fibrillation in older men, Am J Respir Crit Care Med, 193, 783, 10.1164/rccm.201508-1523OC · DOI
- Michniewicz, 2018, Patients with atrial fibrillation and coronary artery disease – double trouble, Adv Med Sci, 63, 30, 10.1016/j.advms.2017.06.005 · DOI · Paper page
- Monrad, 2017, Long-term exposure to traffic-related air pollution and risk of incident atrial fibrillation: a cohort study, Environ Health Perspect, 125, 422, 10.1289/EHP392 · DOI
- O'Neal, 2015, Coronary artery calcium progression and atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis, Circ Cardiovasc Imaging, 8
- Qureshi, 2015, Al-Mallah MH. Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the Henry Ford Exercise Testing (FIT) Project, Circulation, 131, 1827, 10.1161/CIRCULATIONAHA.114.014833 · DOI · Paper page
- Santhanakrishnan, 2016, Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction, Circulation, 133, 484, 10.1161/CIRCULATIONAHA.115.018614 · DOI · Paper page
- Shen, 2011, Dietary factors and incident atrial fibrillation: the Framingham Heart Study, Am J Clin Nutr, 93, 261, 10.3945/ajcn.110.001305 · DOI
- Svensson, 2017, Psychological stress and risk of incident atrial fibrillation in men and women with known atrial fibrillation genetic risk scores, Sci Rep, 7, 42613, 10.1038/srep42613 · DOI
- Tung, 2017, Obstructive and central sleep apnea and the risk of incident atrial fibrillation in a community cohort of men and women, J Am Heart Assoc, 6, 10.1161/JAHA.116.004500 · DOI
- Walkey, 2013, Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors, Am Heart J, 165, 949, 10.1016/j.ahj.2013.03.020 · DOI
- Lip, 2020, Evaluation of the C2HEST risk score as a possible opportunistic screening tool for incident atrial fibrillation in a healthy population (from a nationwide Danish cohort study), Am J Cardiol, 125, 48, 10.1016/j.amjcard.2019.09.034 · DOI
- Yiin, 2018, Time trends in atrial fibrillation-associated stroke and premorbid anticoagulation, Stroke, STROKEAHA118022249
- Akao, 2013, Current status of clinical background of patients with atrial fibrillation in a community-based survey: the Fushimi AF Registry, J Cardiol, 61, 260, 10.1016/j.jjcc.2012.12.002 · DOI · Paper page
- An, 2019, Causes of death in Japanese patients with atrial fibrillation: the Fushimi Atrial Fibrillation Registry, Eur Heart J Qual Care Clin Outcomes, 5, 35, 10.1093/ehjqcco/qcy033 · DOI
- Andersson, 2013, All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case-control study, Eur Heart J, 34, 1061, 10.1093/eurheartj/ehs469 · DOI · Paper page
- Andrew, 2013, The prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made?, Neuroepidemiology, 40, 227, 10.1159/000343667 · DOI
- Bakhai, 2016, Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry, Eur Heart J Qual Care Clin Outcomes, 2, 299, 10.1093/ehjqcco/qcw031 · DOI
- Benjamin, 1998, Impact of atrial fibrillation on the risk of death: the Framingham Heart Study, Circulation, 98, 946, 10.1161/01.CIR.98.10.946 · DOI · Paper page
- Blum, 2017, Prospective assessment of sex-related differences in symptom status and health perception among patients with atrial fibrillation, J Am Heart Assoc, 6, e005401, 10.1161/JAHA.116.005401 · DOI
- Boriani, 2015, Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry, Am J Med, 128, 509, 10.1016/j.amjmed.2014.11.026 · DOI · Paper page
- Ceornodolea, 2017, Epidemiology and management of atrial fibrillation and stroke: review of data from four European countries, Stroke Res Treat, 2017, 8593207
- Chao, 2016, Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation: a nationwide cohort study, Stroke, 47, 2462, 10.1161/STROKEAHA.116.013880 · DOI
- Dagres, 2018, European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?, EP Europace, 20, 1399, 10.1093/europace/euy046 · DOI
- Esato, 2017, Clinical impact of asymptomatic presentation status in patients with paroxysmal and sustained atrial fibrillation: the Fushimi AF Registry, Chest, 152, 1266, 10.1016/j.chest.2017.08.004 · DOI
- Freeman, 2015, Association between atrial fibrillation symptoms, quality of life, and patient outcomes: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF), Circ Cardiovasc Qual Outcomes, 8, 393, 10.1161/CIRCOUTCOMES.114.001303 · DOI · Paper page
- Frost, 2001, Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation, Arch Intern Med, 161, 272, 10.1001/archinte.161.2.272 · DOI
- Gaita, 2013, Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function, J Am Coll Cardiol, 62, 1990, 10.1016/j.jacc.2013.05.074 · DOI · Paper page
- Garcia-Fernandez, 2017, Applicability of the modified CHA2DS2-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients, Eur J Intern Med, 38, e21, 10.1016/j.ejim.2016.11.006 · DOI
- Gleason, 2018, Atrial fibrillation symptoms and sex, race, and psychological distress: a literature review, J Cardiovasc Nurs, 33, 137, 10.1097/JCN.0000000000000421 · DOI
- Gomez-Outes, 2016, Causes of death in anticoagulated patients with atrial fibrillation, J Am Coll Cardiol, 68, 2508, 10.1016/j.jacc.2016.09.944 · DOI · Paper page
- Graves, 2017, Atrial fibrillation incrementally increases dementia risk across all CHADS2 and CHA2DS2VASc strata in patients receiving long-term warfarin, Am Heart J, 188, 93, 10.1016/j.ahj.2017.02.026 · doi:10.1016/j.ahj.2017.02.026
- John, 2018, Atrial fibrillation hospitalization, mortality, and therapy, Eur Heart J, 39, 3958, 10.1093/eurheartj/ehy622 · DOI
- Kalantarian, 2016, Atrial fibrillation and cognitive decline: phenomenon or epiphenomenon?, Cardiol Clin, 34, 279
- Kalantarian, 2013, Cognitive impairment associated with atrial fibrillation: a meta-analysis, Ann Intern Med, 158, 338, 10.7326/0003-4819-158-5-201303050-00007 · DOI · Paper page
- Kim, 2011, Estimation of total incremental health care costs in patients with atrial fibrillation in the United States, Circ Cardiovasc Qual Outcomes, 4, 313, 10.1161/CIRCOUTCOMES.110.958165 · DOI · Paper page
- Kochhauser, 2016, The impact of duration of atrial fibrillation recurrences on measures of health-related quality of life and symptoms, Pacing Clin Electrophysiol, 39, 166, 10.1111/pace.12772 · DOI
- Konig, 2018, In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures, Eur Heart J, 39, 3947, 10.1093/eurheartj/ehy528 · DOI
- Kotecha, 2016, Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins, J Am Coll Cardiol, 68, 2217, 10.1016/j.jacc.2016.08.048 · DOI · Paper page
- Kupper, 2018, Type D personality affects health-related quality of life in patients with lone atrial fibrillation by increasing symptoms related to sympathetic activation, J Psychosom Res, 115, 44, 10.1016/j.jpsychores.2018.10.005 · DOI
- Kwok, 2011, Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis, Neurology, 76, 914, 10.1212/WNL.0b013e31820f2e38 · DOI · Paper page
- Levy, 1999, Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists, Circulation, 99, 3028, 10.1161/01.CIR.99.23.3028 · DOI · Paper page
- Lin, 1996, Stroke severity in atrial fibrillation. The Framingham Study, Stroke, 27, 1760, 10.1161/01.STR.27.10.1760 · DOI · Paper page
- Lip, 2015, Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot Survey on Atrial Fibrillation, Europace, 17, 24, 10.1093/europace/euu155 · DOI · Paper page
- McCabe, 2015, Patients’ experiences from symptom onset to initial treatment for atrial fibrillation, J Clin Nurs, 24, 786, 10.1111/jocn.12708 · DOI
- McCabe, 2011, Living with atrial fibrillation: a qualitative study, J Cardiovasc Nurs, 26, 336, 10.1097/JCN.0b013e31820019b9 · DOI
- Meyre, 2019, Risk of hospital admissions in patients with atrial fibrillation: a systematic review and meta-analysis, Can J Cardiol, 35, 1332
- Nieuwlaat, 2005, Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation, Eur Heart J, 26, 2422, 10.1093/eurheartj/ehi505 · DOI · Paper page
- Overvad, 2017, Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score, Eur Heart J Cardiovasc Pharmacother, 3, 37, 10.1093/ehjcvp/pvw022 · DOI
- Piccini, 2016, Rhythm control in atrial fibrillation, Lancet, 388, 829, 10.1016/S0140-6736(16)31277-6 · DOI
- Pistoia, 2016, The epidemiology of atrial fibrillation and stroke, Cardiol Clin, 34, 255
- Pokorney, 2016, Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF, J Am Heart Assoc, 5, e002197, 10.1161/JAHA.115.002197 · DOI · Paper page
- Potpara, 2013, A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study, Int J Cardiol, 168, 4744, 10.1016/j.ijcard.2013.07.234 · DOI
- Randolph, 2016, Patient factors associated with quality of life in atrial fibrillation, Am Heart J, 182, 135, 10.1016/j.ahj.2016.08.003 · DOI
- Rienstra, 2012, Symptoms and functional status of patients with atrial fibrillation: state-of-the-art and future research opportunities, Circulation, 125, 2933, 10.1161/CIRCULATIONAHA.111.069450 · DOI · Paper page
- Rienstra, 2014, Asymptomatic persistent atrial fibrillation and outcome: results of the RACE study, Heart Rhythm, 11, 939, 10.1016/j.hrthm.2014.03.016 · DOI
- Rivard, 2017, Mechanisms, clinical significance, and prevention of cognitive impairment in patients with atrial fibrillation, Can J Cardiol, 33, 1556
- Santangeli, 2012, Atrial fibrillation and the risk of incident dementia: a meta-analysis, Heart Rhythm, 9, 1761, 10.1016/j.hrthm.2012.07.026 · DOI · Paper page
- Schnabel, 2013, Depression in atrial fibrillation in the general population, PLoS One, 8, e79109, 10.1371/journal.pone.0079109 · DOI
- Schnabel, 2017, Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation, Heart, 103, 1024, 10.1136/heartjnl-2016-310406 · DOI · Paper page
- Senoo, 2012, Distribution of first-detected atrial fibrillation patients without structural heart diseases in symptom classifications, Circ J, 76, 1020, 10.1253/circj.CJ-12-0105 · DOI
- Serpytis, 2018, Impact of atrial fibrillation on cognitive function, psychological distress, quality of life, and impulsiveness, Am J Med, 131, 703.e1-703, 10.1016/j.amjmed.2017.12.044 · DOI
- Siontis, 2016, Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications, Heart Rhythm, 13, 1418, 10.1016/j.hrthm.2016.03.003 · DOI · Paper page
- Steg, 2012, Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry, Heart, 98, 195, 10.1136/heartjnl-2011-300550 · DOI
- Streur, 2017, Symptom clusters in adults with chronic atrial fibrillation, J Cardiovasc Nurs, 32, 296, 10.1097/JCN.0000000000000344 · DOI
- Thrall, 2007, Depression, anxiety, and quality of life in patients with atrial fibrillation, Chest, 132, 1259, 10.1378/chest.07-0036 · DOI · Paper page
- Ugowe, 2019, Jackson LRn. Atrial fibrillation and mortality risk: seeing the big picture, Eur Heart J Qual Care Clin Outcomes, 5, 6, 10.1093/ehjqcco/qcy050 · DOI
- Vermond, 2014, Symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II study, Europace, 16, 1417, 10.1093/europace/euu151 · DOI
- Walters, 2018, Psychological distress and suicidal ideation in patients with atrial fibrillation: prevalence and response to management strategy, J Am Heart Assoc, 7, e005502, 10.1161/JAHA.117.005502 · DOI
- Walters, 2019, Symptom severity and quality of life in patients with atrial fibrillation: psychological function outweighs clinical predictors, Int J Cardiol, 279, 84, 10.1016/j.ijcard.2018.10.101 · DOI
- Wang, 2003, A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study, JAMA, 290, 1049, 10.1001/jama.290.8.1049 · DOI · Paper page
- Wijesurendra, 2015, Atrial fibrillation: effects beyond the atrium?, Cardiovasc Res, 105, 238, 10.1093/cvr/cvv001 · DOI
- Ziff, 2018, The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: insights from the United Kingdom ACALM registry, Int J Cardiol, 252, 117, 10.1016/j.ijcard.2017.06.033 · DOI
- Sepehri Shamloo, 2020, Atrial fibrillation and cognitive impairment: new insights and future directions, Heart Lung Circ, 29, 69, 10.1016/j.hlc.2019.05.185 · DOI
- Conen, 2019, Relationships of overt and silent brain lesions with cognitive function in patients with atrial fibrillation, J Am Coll Cardiol, 73, 989, 10.1016/j.jacc.2018.12.039 · DOI · Paper page
- Kirchhof, 2016, 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, 37, 2893, 10.1093/eurheartj/ehw210 · DOI · Paper page
- Boriani, 2014, AF burden is important – fact or fiction?, Int J Clin Pract, 68, 444, 10.1111/ijcp.12326 · DOI
- Boriani, 2016, Atrial fibrillation burden and atrial fibrillation type: clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation, Vascul Pharmacol, 83, 26, 10.1016/j.vph.2016.03.006 · DOI
- Wyse, 2014, Lone atrial fibrillation: does it exist?, J Am Coll Cardiol, 63, 1715, 10.1016/j.jacc.2014.01.023 · DOI · Paper page
- Lip, 2017, Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE), Europace, 19, 1757, 10.1093/europace/eux240 · DOI
- Brieger, 2018, National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the diagnosis and management of atrial fibrillation 2018, Heart Lung Circ, 27, 1209, 10.1016/j.hlc.2018.06.1043 · DOI · Paper page
- Chen, 2018, Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association, Circulation, 137, e623, 10.1161/CIR.0000000000000568 · DOI · Paper page
- Ziegler, 2006, Comparison of continuous versus intermittent monitoring of atrial arrhythmias, Heart Rhythm, 3, 1445, 10.1016/j.hrthm.2006.07.030 · DOI · Paper page
- Boriani, 2018, Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) long-term general registry, Europace, 20, 747, 10.1093/europace/eux301 · DOI · Paper page
- Pandey, 2017, Predictors and prognostic implications of incident heart failure in patients with prevalent atrial fibrillation, JACC Heart Fail, 5, 44, 10.1016/j.jchf.2016.09.016 · DOI
- Ganesan, 2016, The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis, Eur Heart J, 37, 1591, 10.1093/eurheartj/ehw007 · DOI · Paper page
- Al-Khatib, 2013, Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial, Eur Heart J, 34, 2464, 10.1093/eurheartj/eht135 · DOI · Paper page
- Link, 2017, Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48, Circ Arrhythm Electrophysiol, 10, e004267, 10.1161/CIRCEP.116.004267 · DOI
- Steinberg, 2015, Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial, Eur Heart J, 36, 288, 10.1093/eurheartj/ehu359 · DOI · Paper page
- Hart, 2000, Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators, J Am Coll Cardiol, 35, 183, 10.1016/S0735-1097(99)00489-1 · DOI · Paper page
- Takabayashi, 2015, Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation: the Fushimi Atrial Fibrillation Registry, Stroke, 46, 3354, 10.1161/STROKEAHA.115.010947 · DOI
- Nieuwlaat, 2008, Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?, Eur Heart J, 29, 915, 10.1093/eurheartj/ehn101 · DOI
- Go, 2018, Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM Study, JAMA Cardiol, 3, 601, 10.1001/jamacardio.2018.1176 · DOI · Paper page
- Ecker, 2018, A review of factors associated with maintenance of sinus rhythm after elective electrical cardioversion for atrial fibrillation, Clin Cardiol, 41, 862, 10.1002/clc.22931 · DOI
- Nyong, 2016, Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation, Cochrane Database Syst Rev, 11, CD012088
- Piccini, 2019, Atrial fibrillation burden, progression, and the risk of death: a case-crossover analysis in patients with cardiac implantable electronic devices, Europace, 21, 404, 10.1093/europace/euy222 · DOI
- Deng, 2017, Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review, Clin Res Cardiol, 106, 813, 10.1007/s00392-017-1123-0 · DOI
- Potpara, 2012, A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation Study, Chest, 141, 339, 10.1378/chest.11-0340 · DOI
- Goette, 2016, EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication, Europace, 18, 1455, 10.1093/europace/euw161 · DOI · Paper page
- Nattel, 2014, Early management of atrial fibrillation to prevent cardiovascular complications, Eur Heart J, 35, 1448, 10.1093/eurheartj/ehu028 · DOI · Paper page
- Freedman, 2017, Screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration, Circulation, 135, 1851, 10.1161/CIRCULATIONAHA.116.026693 · DOI · Paper page
- Mairesse, 2017, Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE, Europace, 19, 1589, 10.1093/europace/eux177 · DOI
- Padfield, 2017, Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation, Heart Rhythm, 14, 801, 10.1016/j.hrthm.2017.01.038 · DOI · Paper page
- Vidal-Perez, 2013, The change in the atrial fibrillation type as a prognosis marker in a community study: long-term data from AFBAR (Atrial Fibrillation in the BARbanza) study, Int J Cardiol, 168, 2146, 10.1016/j.ijcard.2013.01.261 · DOI
- de Vos, 2010, Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis, J Am Coll Cardiol, 55, 725, 10.1016/j.jacc.2009.11.040 · DOI · Paper page
- Hobbelt, 2017, Prethrombotic state in young very low-risk patients with atrial fibrillation, J Am Coll Cardiol, 69, 1990, 10.1016/j.jacc.2017.01.057 · doi:10.1016/j.jacc.2017.01.057
- Habibi, 2016, Cardiac magnetic resonance-measured left atrial volume and function and incident atrial fibrillation: results from MESA (Multi-Ethnic Study of Atherosclerosis), Circ Cardiovasc Imaging, 9, e004299, 10.1161/CIRCIMAGING.115.004299 · DOI
- Guichard, 2017, Atrial Cardiomyopathy: A useful notion in cardiac disease management or a passing fad?, J Am Coll Cardiol, 70, 756, 10.1016/j.jacc.2017.06.033 · DOI · Paper page
- Hirsh, 2015, Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences, J Am Coll Cardiol, 65, 2239, 10.1016/j.jacc.2015.03.557 · DOI · Paper page
- Freedman, 2016, Stroke prevention in atrial fibrillation, Lancet, 388, 806, 10.1016/S0140-6736(16)31257-0 · DOI · Paper page
- Martinez, 2014, Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study, Thromb Haemost, 112, 276, 10.1160/TH4-04-0383 · DOI
- Wilson, 1968, [Principles and practice of mass screening for disease], Bol Oficina Sanit Panam, 65, 281
- Welton, 2017, Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis, Health Technol Assess, 21, 1, 10.3310/hta21290 · DOI
- Schnabel, 2019, Searching for atrial fibrillation poststroke: a white paper of the AF-SCREEN International Collaboration, Circulation, 140, 1834, 10.1161/CIRCULATIONAHA.119.040267 · DOI
- Yan, 2018, Contact-free screening of atrial fibrillation by a smartphone using facial pulsatile photoplethysmographic signals, J Am Heart Assoc, 7, 10.1161/JAHA.118.008585 · DOI
- Orchard, 2016, Screening for atrial fibrillation during influenza vaccinations by primary care nurses using a smartphone electrocardiograph (iECG): a feasibility study, Eur J Prev Cardiol, 23, 13, 10.1177/2047487316670255 · DOI
- Lampert, 2018, Screening for atrial fibrillation using smartphone-based technology and layperson volunteers: high-tech meets community participatory research for the best of both worlds, Heart Rhythm, 15, 1312, 10.1016/j.hrthm.2018.07.005 · DOI
- Lahdenoja, 2018, Atrial fibrillation detection via accelerometer and gyroscope of a smartphone, IEEE J Biomed Health Inform, 22, 108, 10.1109/JBHI.2017.2688473 · DOI
- Freedman, 2016, Screening for atrial fibrillation using a smartphone: is there an app for that?, J Am Heart Assoc, 5, 10.1161/JAHA.116.004000 · DOI
- Brasier, 2019, Detection of atrial fibrillation with a smartphone camera: first prospective, international, two-centre, clinical validation study (DETECT AF PRO), Europace, 21, 41, 10.1093/europace/euy176 · DOI
- Tison, 2018, Passive detection of atrial fibrillation using a commercially available smartwatch, JAMA Cardiol, 3, 409, 10.1001/jamacardio.2018.0136 · DOI · Paper page
- Li, 2019, The current state of mobile phone apps for monitoring heart rate, heart rate variability, and atrial fibrillation: narrative review, JMIR Mhealth Uhealth, 7, e11606, 10.2196/11606 · DOI
- Wasserlauf, 2019, Smartwatch performance for the detection and quantification of atrial fibrillation, Circ Arrhythm Electrophysiol, 12, e006834, 10.1161/CIRCEP.118.006834 · DOI · Paper page
- Harris, 2012, How can we best detect atrial fibrillation?, J R Coll Physicians Edinb, 42 Suppl 18, 5, 10.4997/JRCPE.2012.S02. · DOI
- Wiesel, 2004, The use of a modified sphygmomanometer to detect atrial fibrillation in outpatients, Pacing Clin Electrophysiol, 27, 639, 10.1111/j.1540-8159.2004.00499.x · DOI
- Wiesel, 2009, Detection of atrial fibrillation using a modified microlife blood pressure monitor, Am J Hypertens, 22, 848, 10.1038/ajh.2009.98 · DOI
- Stergiou, 2009, Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation, J Hum Hypertens, 23, 654, 10.1038/jhh.2009.5 · DOI
- Willits, 2014, WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension: a, NICE Medical Technology Guidance. Appl Health Econ Health Policy, 12, 255, 10.1007/s40258-014-0096-7 · DOI
- Desteghe, 2017, Performance of handheld electrocardiogram devices to detect atrial fibrillation in a cardiology and geriatric ward setting, Europace, 19, 29
- Kaasenbrood, 2016, Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead electrocardiogram device during influenza vaccination, Europace, 18, 1514, 10.1093/europace/euv426 · DOI
- Jacobs, 2018, Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands, Europace, 20, 12
- Lowres, 2014, Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study, Thromb Haemost, 111, 1167, 10.1160/TH14-03-0231 · DOI · Paper page
- Nemati, 2016, Monitoring and detecting atrial fibrillation using wearable technology, Conf Proc IEEE Eng Med Biol Soc, 2016, 3394
- Petryszyn, 2019, Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis, PLoS One, 14, e0213198, 10.1371/journal.pone.0213198 · DOI
- Orchard, 2018, Atrial fibrillation: is there enough evidence to recommend opportunistic or systematic screening?, Int J Epidemiol, 47, 1361, 10.1093/ije/dyy156 · DOI
- Turakhia, 2015, Economic burden of undiagnosed nonvalvular atrial fibrillation in the United States, Am J Cardiol, 116, 733, 10.1016/j.amjcard.2015.05.045 · DOI
- Fay, 2017, Screening of older patients for atrial fibrillation in general practice: current evidence and its implications for future practice, Eur J Gen Pract, 23, 246, 10.1080/13814788.2017.1374366 · DOI
- Boriani, 2015, Asymptomatic lone atrial fibrillation – how can we detect the arrhythmia?, Curr Pharm Des, 21, 659, 10.2174/1381612820666140825142639 · doi:10.2174/1381612820666140825142639
- Lowres, 2013, Screening to identify unknown atrial fibrillation. A systematic review, Thromb Haemost, 110, 213, 10.1160/TH13-02-0165 · DOI · Paper page
- Engdahl, 2013, Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention, Circulation, 127, 930, 10.1161/CIRCULATIONAHA.112.126656 · DOI · Paper page
- Boriani, 2014, Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices), Eur Heart J, 35, 508, 10.1093/eurheartj/eht491 · DOI · Paper page
- Lowres, 2015, Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation, Int J Clin Pharm, 37, 1111, 10.1007/s11096-015-0169-1 · DOI
- Wynn, 2014, The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification, Europace, 16, 965, 10.1093/europace/eut395 · DOI · Paper page
- De With, 2019, Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study, Europace, 21, 563, 10.1093/europace/euy311 · DOI
- Schnabel, 2018, Symptom burden of atrial fibrillation and its relation to interventions and outcome in Europe, J Am Heart Assoc, 7, 10.1161/JAHA.117.007559 · DOI
- Björkenheim, 2017, Assessment of atrial fibrillation – specific symptoms before and 2 years after atrial fibrillation ablation: do patients and physicians differ in their perception of symptom relief?, JACC: Clinical Electrophysiology, 3, 1168
- Sandhu, 2017, Impact of electrical cardioversion on quality of life for the treatment of atrial fibrillation, Can J Cardiol, 33, 450
- Gilbert, 2015, Restoration of sinus rhythm results in early and late improvements in the functional reserve of the heart following direct current cardioversion of persistent AF: FRESH-AF, Int J Cardiol, 199, 121, 10.1016/j.ijcard.2015.07.020 · doi:10.1016/j.ijcard.2015.07.020
- Jais, 2008, Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study, Circulation, 118, 2498, 10.1161/CIRCULATIONAHA.108.772582 · DOI · Paper page
- Oral, 2006, Circumferential pulmonary-vein ablation for chronic atrial fibrillation, N Engl J Med, 354, 934, 10.1056/NEJMoa050955 · DOI · Paper page
- Wilber, 2010, Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial, JAMA, 303, 333, 10.1001/jama.2009.2029 · DOI · Paper page
- Pokorney, 2017, Cardioversion and subsequent quality of life and natural history of atrial fibrillation, Am Heart J, 185, 59, 10.1016/j.ahj.2016.10.018 · DOI
- Mantovan, 2013, Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: substudy of the STAR AF randomized trial, Can J Cardiol, 29, 1211
- Blomstrom-Lundqvist, 2019, Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial, JAMA, 321, 1059, 10.1001/jama.2019.0335 · DOI · Paper page
- Mark, 2019, Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial, JAMA, 10.1001/jama.2019.0692 · DOI · Paper page
200 of 1261 shown
Cited by
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citation2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Self-citation2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab395 · Cited by 5,685
Self-citation2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
Self-citationMancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Metadata
- Authors
- Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., Fauchier, L., Filippatos, G., Kalman, J. M., La Meir, M., Lane, D. A., Lebeau, J.-P., Lettino, M., Lip, G. Y. H., Pinto, F. J., Thomas, G. N., Valgimigli, M., Van Gelder, I. C., Van Putte, B. P., Watkins, C. L., ESC Scientific Document Group, Kirchhof, P., Kühne, M., Aboyans, V., Ahlsson, A., Balsam, P., Bauersachs, J., Benussi, S., Brandes, A., Braunschweig, F., Camm, A. J., Capodanno, D., Casadei, B., Conen, D., Crijns, H. J. G. M., Delgado, V., Dobrev, D., Drexel, H., Eckardt, L., Fitzsimons, D., Folliguet, T., Gale, C. P., Gorenek, B., Haeusler, K. G., Heidbuchel, H., Iung, B., Katus, H. A., Kotecha, D., Landmesser, U., Leclercq, C., Lewis, B. S., Mascherbauer, J., Merino, J. L., Merkely, B., Mont, L., Mueller, C., Nagy, K. V., Oldgren, J., Pavlović, N., Pedretti, R. F. E., Petersen, S. E., Piccini, J. P., Popescu, B. A., Pürerfellner, H., Richter, D. J., Roffi, M., Rubboli, A., Scherr, D., Schnabel, R. B., Simpson, I. A., Shlyakhto, E., Sinner, M. F., Steffel, J., Sousa-Uva, M., Suwalski, P., Svetlosak, M., Touyz, R. M., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., Fauchier, L., Filippatos, G., Kalman, J. M., La Meir, M., Lane, D. A., Lebeau, J.-P., Lettino, M., Lip, G. Y. H., Pinto, F. J., Neil Thomas, G., Valgimigli, M., Van Gelder, I. C., Watkins, C. L., Delassi, T., Sisakian, H. S., Scherr, D., Chasnoits, A., Pauw, M. D., Smajić, E., Shalganov, T., Avraamides, P., Kautzner, J., Gerdes, C., Alaziz, A. A., Kampus, P., Raatikainen, P., Boveda, S., Papiashvili, G., Eckardt, L., Vassilikos, V., Csanádi, Z., Arnar, D. O., Galvin, J., Barsheshet, A., Caldarola, P., Rakisheva, A., Bytyçi, I., Kerimkulova, A., Kalejs, O., Njeim, M., Puodziukynas, A., Groben, L., Sammut, M. A., Grosu, A., Boskovic, A., Moustaghfir, A., Groot, N. D., Poposka, L., Anfinsen, O.-G., Mitkowski, P. P., Cavaco, D. M., Siliste, C., Mikhaylov, E. N., Bertelli, L., Kojic, D., Hatala, R., Fras, Z., Arribas, F., Juhlin, T., Sticherling, C., Abid, L., Atar, I., Sychov, O., Bates, M. G. D., & Zakirov, N. U.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-08-29
- Volume
- 42
- Issue
- 5
- Pages
- 373-498
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W3082188176
- Cited by
- 9,971
- References
- 226
- FWCI
- 832.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). https://app.cochat.ai/papers/10.1093/eurheartj/ehaa612
- The paper
- Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., Fauchier, L., Filippatos, G., Kalman, J. M., La Meir, M., Lane, D. A., Lebeau, J.-P., Lettino, M., Lip, G. Y. H., Pinto, F. J., . . . Zakirov, N. U. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. https://doi.org/10.1093/eurheartj/ehaa612
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.